Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03275181 · ClinicalTrials.gov registry record
Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer
A clinical trial of Prostate Cancer, sponsored by Kansas State University.
- Completed
- Registry status
- 18
- Enrollment target
- 1
- Study location
NCT03275181: Completed study of Prostate Cancer, sponsored by Kansas State University.
NCT03275181 is a study of Prostate Cancer that has completed, run by Kansas State University. The registered enrollment target is 18 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03275181, a study of Prostate Cancer, has completed, sponsored by Kansas State University.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this project is to determine whether androgen deprivation therapy (ADT) decreases left ventricular function in prostate cancer patients. If found successful, this may lead to improved cardiovascular health via treatment and/or lifestyle interventions in prostate cancer populations.
Primary Outcome
measure of left ventricular systolic function
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Transthoracic Echocardiography
- DIAGNOSTIC_TEST Arterial blood pressure
- DIAGNOSTIC_TEST Submaximal Exercise
Study Locations (1)
Kansas
- Kansas State University - Clinical Integrative Physiology Laboratory - Manhattan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2018-12-31 |
What the finished NCT03275181 record still lists
NCT03275181 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which Transthoracic Echocardiography is the first listed.
NCT03275181 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT03275181 about?
NCT03275181 is a clinical study titled "Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer". The aim of this project is to determine whether androgen deprivation therapy (ADT) decreases left ventricular function in prostate cancer patients. If found successful, this may lead to improved cardiovascular health via treatment and/or lifestyle interventions in prostate cancer populations.
What is the current status of trial NCT03275181?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2017-08-01. Estimated completion is 2018-12-31.
What conditions does trial NCT03275181 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT03275181?
The interventions under investigation include: Transthoracic Echocardiography (DIAGNOSTIC_TEST), Arterial blood pressure (DIAGNOSTIC_TEST), Submaximal Exercise (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03275181?
This trial is sponsored by Kansas State University, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03275181 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03275181's enrollment target sits among peer trials
18 675th of 735 higher than 56 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI